Found 5 results
Filters: Author is Cattran, Daniel C  [Clear All Filters]
2016
Gipson DS, Troost JP, Lafayette RA, Hladunewich MA, Trachtman H, Gadegbeku CA, Sedor JR, Holzman LB, Moxey-Mims MM, Perumal K et al..  2016.  Complete Remission in the Nephrotic Syndrome Study Network.. Clin J Am Soc Nephrol. 11(1):81-9.
Sampson MG, Robertson CC, Martini S, Mariani LH, Lemley KV, Gillies CE, Otto EA, Kopp JB, Randolph A, Vega-Warner V et al..  2016.  Integrative Genomics Identifies Novel Associations with APOL1 Risk Genotypes in Black NEPTUNE Subjects.. J Am Soc Nephrol. 27(3):814-23.
2014
Hodgin JB, Berthier CC, John R, Grone E, Porubsky S, Gröne H-J, Herzenberg AM, Scholey JW, Hladunewich M, Cattran DC et al..  2014.  The molecular phenotype of endocapillary proliferation: novel therapeutic targets for IgA nephropathy.. PLoS One. 9(8):e103413.
2013
Ashraf S, Gee HYung, Woerner S, Xie LX, Vega-Warner V, Lovric S, Fang H, Song X, Cattran DC, Avila-Casado C et al..  2013.  ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption.. J Clin Invest. 123(12):5179-89.
Gadegbeku CA, Gipson DS, Holzman LB, Ojo AO, Song PXK, Barisoni L, Sampson MG, Kopp JB, Lemley KV, Nelson PJ et al..  2013.  Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach.. Kidney Int. 83(4):749-56.